News & Updates

Product Highlight - Etoricoxib (Ebicox)

10 Jun 2025

Film-coated tablet 90 mg and 120 mg

Product Highlight - Etoricoxib (Ebicox)

10 Jun 2025

Product Highlight - Somatostatin acetate (Somaset)

10 Jun 2025

Powder for injection 3 mg

Product Highlight - Somatostatin acetate (Somaset)

10 Jun 2025

Product Highlight - Acetylcysteine (Fluimucil)

10 Jun 2025

Effervescent tablet 600 mg and Granules for oral solution 600 mg

Product Highlight - Acetylcysteine (Fluimucil)

10 Jun 2025

Product Highlight - Clotrimazole (Candigo®)

10 Jun 2025

Vaginal cream 100 mg/g (10% w/w) and Vaginal suppository 100 mg and 500 mg

Product Highlight - Clotrimazole (Candigo®)

10 Jun 2025

Product Highlight - Valganciclovir hydrochloride (Valvir-450)

10 Jun 2025

Film-coated tablet 450 mg

Product Highlight - Valganciclovir hydrochloride (Valvir-450)

10 Jun 2025

Low-dose methotrexate of little benefit in knee OA with effusion-synovitis

09 Jun 2025

In patients with knee osteoarthritis (OA) with effusion, the use of low-dose methotrexate does not appear to relieve pain or reduce effusion-synovitis, as reported in a study.

Low-dose methotrexate of little benefit in knee OA with effusion-synovitis

09 Jun 2025

Single hyaluronic acid jab may be beneficial in managing vulvovaginal atrophy

09 Jun 2025 by

A single injection of cross-linked hyaluronic acid appears to help reduce vulvovaginal symptoms (VVA) and improve sexual dysfunction in postmenopausal women, as shown in a study.

Single hyaluronic acid jab may be beneficial in managing vulvovaginal atrophy

09 Jun 2025

Medication adherence helps lower CVD-related hospitalizations in older adults

09 Jun 2025 by

Adherence to medications contributes to a reduced risk of hospitalization due to cardiovascular disease (CVD) in older people with coronary heart disease (CHD), reports a Vietnam study.

Medication adherence helps lower CVD-related hospitalizations in older adults

09 Jun 2025

What drives prolonged recovery in older patients after rocuronium exposure?

09 Jun 2025

Older patients experience a slightly longer recovery time than their younger counterparts following administration of general anaesthesia, which is caused by an age-dependent increase in tissue uptake, a recent study has shown.

What drives prolonged recovery in older patients after rocuronium exposure?

09 Jun 2025

Efruxifermin reduces fibrosis in MASH cirrhosis

09 Jun 2025 by

The long-acting, bivalent fibroblast growth factor 21 analogue efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) in the phase 2b SYMMETRY trial.

Efruxifermin reduces fibrosis in MASH cirrhosis

09 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Product Highlight - Etoricoxib (Ebicox)

Product Highlight - Etoricoxib (Ebicox)

Product Highlight - Somatostatin acetate (Somaset)

Product Highlight - Somatostatin acetate (Somaset)

Product Highlight - Acetylcysteine (Fluimucil)

Product Highlight - Acetylcysteine (Fluimucil)

Product Highlight - Clotrimazole (Candigo®)

Product Highlight - Clotrimazole (Candigo®)

Product Highlight - Valganciclovir hydrochloride (Valvir-450)

Product Highlight - Valganciclovir hydrochloride (Valvir-450)

Low-dose methotrexate of little benefit in knee OA with effusion-synovitis

Low-dose methotrexate of little benefit in knee OA with effusion-synovitis

Single hyaluronic acid jab may be beneficial in managing vulvovaginal atrophy

Single hyaluronic acid jab may be beneficial in managing vulvovaginal atrophy

Medication adherence helps lower CVD-related hospitalizations in older adults

Medication adherence helps lower CVD-related hospitalizations in older adults

What drives prolonged recovery in older patients after rocuronium exposure?

What drives prolonged recovery in older patients after rocuronium exposure?

Efruxifermin reduces fibrosis in MASH cirrhosis

Efruxifermin reduces fibrosis in MASH cirrhosis